Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 10 - Immunotherapy I
- 11:00 - 12:30
- 10/17/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:S. Wang, Robert Pirker
-
+
MA 10.01 - Durvalumab ± Tremelimumab with Platinum-Doublets in Non-Small Cell Lung Cancer: Canadian Cancer Trials Group Study IND.226
11:00 - 11:05 | Presenter: Desiree Hao | Author(s): R.A. Juergens*, S.A. Laurie, P.M. Ellis, M. Mates, Penelope Bradbury, M. Tehfe, C. Kollmannsberger, A. Arnold, John R Goffin, P. Wheatley-Price, J. Hilton, A.G. Robinson, D. Tu, P. Brown-Walker, L. Seymour
- Abstract
Loading... -
+
MA 10.02 - Nab-Paclitaxel + Durvalumab as Second- or Third-Line Treatment of Advanced NSCLC: Results from ABOUND.2L+
11:05 - 11:10 | Presenter: Ramaswamy Govindan | Author(s): Manuel Cobo Dols, S.P. Aix, Pieter E. Postmus, C. Lewanski, Jaafar Bennouna, J.R. Fischer, O.J. Vidal, David James Stewart, A. Ardizoni, J. Weaver, M. Wolfsteiner, Martin Reck, D. Talbot, D. Morgensztern, T.J. Ong
- Abstract
Loading... -
+
MA 10.03 - 3-Year Survival and Duration of Response in Randomized Phase II Study of Atezolizumab vs Docetaxel in 2L/3L NSCLC (POPLAR)
11:10 - 11:15 | Presenter: Keunchil Park | Author(s): C. Lewanski, Shirish M Gadgeel, L. Fehrenbacher, Julien Mazieres, A. Rittmeyer, Ji-Youn Han, A. Artal-Cortes, F. Braiteh, M. Gandhi, W. Yu, C. Matheny, P. He, A. Sandler, M. Ballinger, Johan F. Vansteenkiste
- Abstract
Loading... -
+
MA 10.04 - Discussant - MA 10.01, MA 10.02, MA 10.03
11:15 - 11:30 | Presenter: Wan-Teck Lim
- Abstract
No abstract available for this presentation
-
+
MA 10.05 - Improved Outcome for Immune Checkpoint Inhibitors (ICI) in Patients Previously Treated with Bavituximab in the SUNRISE Trial
11:30 - 11:35 | Presenter: Michael Boyer | Author(s): David R Spigel, P. Mainwaring, H. Lena, M. McCleod, G. Losonczy, R.E. Sanborn, R. Natale, M. Tang, J. Lai, N.L. Kallinteris, Joseph Shan, David E Gerber
- Abstract
Loading... -
+
MA 10.06 - Real-World Results in Non-Squamous Non-Small Cell Lung Cancer Patients: Italian Nivolumab Expanded Access Programme
11:35 - 11:40 | Presenter: Francesco Grossi | Author(s): Lucio Crinò, A. Delmonte, D. Turci, D. Signorelli, F. De Marinis, H.J. Soto Parra, Domenico Galetta, Frederico Cappuzzo, F. Sperandi, M. Tiseo, G. Puppo, F. Roila, Maria Rita Migliorino, G. Tonini, F. Cognetti, A. Santoro, D. Tassinari, A. Scoppola, D. Giannarelli, Enrico Cortesi
- Abstract
Loading... -
+
MA 10.07 - Elderly Lung Cancer Patients on Immunotherapy: Preliminary Results from the ELDERS Study
11:40 - 11:45 | Presenter: Fabio Gomes | Author(s): S. Woolley, R. Califano, Y. Summers, K. Baker, K. Burns, J. Yorke, Fiona Blackhall
- Abstract
Loading... -
+
MA 10.08 - Discussant - MA 10.05, MA 10.06, MA 10.07
11:45 - 12:00 | Presenter: Hidehito Horinouchi
- Abstract
No abstract available for this presentation
-
+
MA 10.09 - Increased T Follicular Helper Cell Infiltration in Lung Adenocarcinoma Tertiary Lymphoid Organs
12:00 - 12:05 | Presenter: Erin Anne Marshall | Author(s): K.W. Ng, Katey S.S. Enfield, S.D. Martin, K. Milne, S.H.Y. Kung, C.E. Macaulay, W.L. Lam
- Abstract
Loading... -
+
MA 10.10 - Tumor Draining Lymph Node Immunophenotype Corresponds with Primary Tumor Characteristics in Patients with Non-Small Cell Lung Cancer
12:05 - 12:10 | Presenter: Daniel H. Sterman | Author(s): V. Murthy, J.J. Tsay, J. Minehart, K. Mangalick, J.L. Bessich, G.C. Michaud, M.A. Curotto De Lafaille, Kwok-Kin Wong, C. Goparaju, Harvey I Pass
- Abstract
Loading... -
+
MA 10.11 - Hyperprogressive Disease (HPD) Is Frequent in Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Treated with Anti PD1/PD-L1 Agents (IO)
12:10 - 12:15 | Presenter: Roberto Ferrara | Author(s): C. Caramella, M. Texier, C. Audigier-Valette, L. Tessonnier, Laura Mezquita, J. Lahmar, Julien Mazieres, G. Zalcman, S. Brosseau, Virginie Westeel, S. Le Moulec, L. Leroy, B. Duchemann, C. Lefebvre, R. Veillon, S. Champiat, C. Fertè, David Planchard, Marie-Eve Boucher, G. Martinez-Bernal, E. Bria, G. Tortora, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
MA 10.12 - Discussant - MA 10.09, MA 10.10, MA 10.11
12:15 - 12:30 | Presenter: David E Gerber
- Abstract
No abstract available for this presentation
-
+
MA 11 - Emerging Diagnostic/Biomarkers in NSCLC
- 11:00 - 12:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:M.I. Abdul Wahid, Martin Reck
-
+
MA 11.01 - Liquid Biopsies for Monitoring BRAF Mutation (V600E) in Advanced BRAF (V600E) Non-Small Cell Lung Cancer (NSCLC)
11:00 - 11:05 | Presenter: Laura Mezquita | Author(s): C. Jovelet, M. Ngocamus, E. Auclin, J. Remon, E. Green, V. Plagnol, C. Morris, A. Gazzah, C. Caramella, J. Adam, L. Lacroix, L. Friboulet, J. Soria, Benjamin Besse, David Planchard
- Abstract
Loading... -
+
MA 11.02 - Circulating Tumour DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update
11:05 - 11:10 | Presenter: Robert Campbell Rintoul | Author(s): A. Ruiz-Valdepenas, K. Heider, G. Doughton, W. Qian, C.E. Massie, D. Chandrananda, C.G. Smith, D. Gale, E. Moseley, C. Castedo, A. Stone, C. Thorbinson, T.G. Eisen, D.M. Rassl, S.V. Harden, N. Rosenfeld
- Abstract
Loading... -
+
MA 11.03 - Gefitinib as First-Line Treatment of Plasma CtDNA EGFR Mutation-Positive NSCLC Detected by DdPCR: BENEFIT Study (CTONG1405)
11:10 - 11:15 | Presenter: Jie Wang | Author(s): Ying Cheng, Yi-Long Wu, T. An, H. Gao, K. Wang, Qing Zhou, Y. Hu, Yong Song, C. Ding, F. Peng, L. Liang, Y. Hu, C. Huang, Caicun Zhou, Y. Shi, Li Zhang, X. Ye, Y. Sun
- Abstract
Loading... -
+
MA 11.04 - Discussant - MA 11.01, MA 11.02, MA 11.03
11:15 - 11:30 | Presenter: Hye Ryun Kim
- Abstract
No abstract available for this presentation
-
+
- Abstract
Loading... -
+
MA 11.06 - Retrospective Analysis of NSCLC Testing in Low Tumor Content Samples: Single-Gene Tests, NGS, & the Oncomine™ Dx Target Test
11:35 - 11:40 | Presenter: Tiffany M Yu | Author(s): C.D. Morrison, E.J. Gold, A. Tradonsky, A.J. Layton
- Abstract
Loading... -
+
MA 11.07 - Exosomes-Transmitted MicroRNAs Promote EGFR-TKIs Resistance in NSCLC by Activating PI3K/AKT Signaling Pathway
11:40 - 11:45 | Presenter: Xiaozhen Liu | Author(s): Tao Jiang, X. Li, J. Li, L. Zhang, S. Zhao, Y. Jia, Jinpeng Shi, C. Zhao, M. Qiao, Fei Zhou, J. Zhao, Caicun Zhou
- Abstract
Loading... -
+
MA 11.08 - Discussant - MA 11.05, MA 11.06, MA 11.07
11:45 - 12:00 | Presenter: Justin F Gainor
- Abstract
No abstract available for this presentation
-
+
MA 11.09 - Real World Data of Rebiopsy, Mutation Status, and Its Association with Plasma Genotyping after EGFR TKI Failure in NSCLC
12:00 - 12:05 | Presenter: Min Hee Hong | Author(s): B.C. Ahn, Hye Ryun Kim, S.J. Heo, J.H. Kim, I.Y. Bang, R. Kim, H.W. Jung, H.J. Cho, H. Kim, H. Kim, Byoung Chul Cho
- Abstract
Loading... -
+
MA 11.10 - EGFR TKI Treatment Induces Active Deamination of 5-Methylcytosine and Leads to Acquired T790M Resistant Mutation
12:05 - 12:10 | Presenter: Khaled A Hassan | Author(s): N. El Kadi, L. Wang, A. Davis, N. Brown, G. Kalemkerian
- Abstract
Loading... -
+
MA 11.11 - Italian Nivolumab Expanded Access Program in Non-Squamous NSCLC Patients: Results in Never Smokers and EGFR Positive Patients
12:10 - 12:15 | Presenter: Marina Chiara Garassino | Author(s): Enrico Cortesi, Francesco Grossi, R. Chiari, H.J. Soto Parra, S. Cascinu, F. Cognetti, D. Turci, L. Blasi, C. Bengala, E. Mini, E.E. Baldini, T. Gamucci, G.L. Ceresoli, P. Antonelli, E. Vasile, C. Pinto, Domenico Galetta, M. Macerelli, F. De Marinis
- Abstract
Loading... -
+
MA 11.12 - Discussant - MA 11.09, MA 11.10, MA 11.11
12:15 - 12:30 | Presenter: Nicolas Girard
- Abstract
No abstract available for this presentation
-
+
MA 12 - Circumventing EGFR Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Wan Ling Tan, Nobuyuki Yamamoto
-
+
MA 12.01 - A Phase Ib Study of the Combination of Afatinib and Ruxolitinib in EGFR Mutant NSCLC Progressed on EGFR-TKI: An Updated Analysis
11:00 - 11:05 | Presenter: Ji Soo Park | Author(s): M.H. Hong, Byoung Chul Cho, Hye Ryun Kim
- Abstract
Loading... -
+
MA 12.02 - Phase I/II Study of S49076, a MET/AXL/FGFR Inhibitor, Combined with Gefitinib in NSCLC Patients Progressing on EGFR TKI
11:05 - 11:10 | Presenter: Gee-Chen Chang | Author(s): G. Curigliano, Wan-Teck Lim, S. Viteri, F. Ciardiello, T. Hida, Chia-Chi Lin, H. Murakami, Makoto Nishio, Luis Paz-Ares, F. Cantero, C. Gabarroca, E. Gandossi, N. Kamsu-Kom, S. Pennaforte, M.-. Secouard-Faure, Keunchil Park
- Abstract
Loading... -
+
MA 12.03 - Kinase Fusions as Recurrent Mechanisms of Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
11:10 - 11:15 | Presenter: Sai-Hong Ignatius Ou | Author(s): S.J. Klempner, B. Creelan, W.S. Hsieh, D. Costin, P.J. Stephens, Jeffrey S. Ross, V.A. Miller, Siraj M Ali, A.B. Schrock
- Abstract
Loading... -
+
MA 12.04 - Discussant - MA 12.01, MA 12.02, MA 12.03
11:15 - 11:30 | Presenter: Miguel-Angel Molina-Vila
- Abstract
No abstract available for this presentation
-
+
MA 12.05 - Genomic Profiling of EGFR T790M Mutated Non-Small Cell Lung Cancer to Evaluate the Mechanisms of Resistance to Osimertinib
11:30 - 11:35 | Presenter: Sonam Puri | Author(s): J.K. Hicks, T.C. Knepper, M. Smith, T.A. Boyle, Jhanelle Elaine Gray
- Abstract
Loading... -
+
MA 12.06 - Using Population Dynamics Mathematical Modeling to Optimize an Intermittent Dosing Regimen for Osimertinib in EGFR-Mutant NSCLC
11:35 - 11:40 | Presenter: Xiuning Le | Author(s): S. Chakrabarti, F. Michor, D.B. Costa, Matthew Meyerson
- Abstract
Loading... -
+
MA 12.07 - Adjusted Indirect Comparison of Osimertinib to Chemotherapy in NSCLC Patients with EGFRm T790M Who Progressed after EGFR-TKI
11:40 - 11:45 | Presenter: Christopher Hoyle | Author(s): F. Andersohn, Tetsuya Mitsudomi, Tony SK Mok, James Chih-Hsin Yang, M. Green, H. Mann
- Abstract
Loading... -
+
MA 12.08 - Discussant - MA 12.05, MA 12.06, MA 12.07
11:45 - 12:00 | Presenter: Dae Ho Lee
- Abstract
No abstract available for this presentation
-
+
- Abstract
Loading... -
+
MA 12.10 - Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria
12:05 - 12:10 | Presenter: Lourdes Barrera | Author(s): J.R. Borbolla-Escoboza, E. Montes-Servin, E.O. Macedo-Perez, Feliciano Barron, C. Molina Romero, J.M. Hernandez Martinez, Oscar Arrieta
- Abstract
Loading... -
+
MA 12.11 - The Alteration of T790M Prevalence Between 19 Deletions and L858R in NSCLC After EGFR-TKIs Therapy, a Meta-Analysis
12:10 - 12:15 | Presenter: Hengrui Liang | Author(s): D. Chen, J. He, W. Liang
- Abstract
Loading... -
+
MA 12.12 - Discussant - MA 12.09, MA 12.10, MA 12.11
12:15 - 12:30 | Presenter: Kenneth Obyrne
- Abstract
No abstract available for this presentation
-
+
MS 11 - Combined Modality Treatment for Superior Sulcus Tumors
- 11:00 - 12:30
- 10/17/2017
- Location: Room 503
- Type: Mini Symposium
- Track: Locally Advanced NSCLC
- Moderators:G.D. Castro, Philip Bonomi
-
+
MS 11.01 - Preoperative Chemoradiotherapy Followed by Surgical Resection
11:00 - 11:15 | Presenter: Hideo Kunitoh
- Abstract
Loading... -
+
MS 11.02 - Problems in the Management of Superior Sulcus Tumor
11:15 - 11:30 | Presenter: Georgios Stamatis
- Abstract
Loading... -
+
MS 11.03 - Surgical Approaches in Superior Sulcus Tumor
11:30 - 11:45 | Presenter: Elie Fadel
- Abstract
Loading... -
+
MS 11.04 - Radiation Therapy for Superior Sulcus Tumor
11:45 - 12:00 | Presenter: Suresh Senan
- Abstract
Loading... -
+
MS 11.05 - Definitive Chemoradiotherapy in Superior Sulcus Tumor
12:00 - 12:15 | Presenter: Everett E Vokes
- Abstract
Loading... -
+
MS 11.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 12 - Sustainable Care System in Each Region
- 11:00 - 12:30
- 10/17/2017
- Location: Room 501
- Type: Mini Symposium
- Track: Regional Aspects/Health Policy/Public Health
- Moderators:Yasushi Goto, M.E. Hand
-
+
MS 12.01 - Sustainable Care System in North America
11:00 - 11:15 | Presenter: Glenwood Goss, Natasha B Leighl
- Abstract
No abstract available for this presentation
-
+
MS 12.02 - Sustainable Care System in Europe
11:15 - 11:30 | Presenter: Solange Peters
- Abstract
No abstract available for this presentation
-
+
MS 12.03 - Sustainable Care System in China
11:30 - 11:45 | Presenter: Yi-Long Wu
- Abstract
No abstract available for this presentation
-
+
MS 12.04 - Sustainable Care System in Philippines
11:45 - 12:00 | Presenter: Gerardo de Hitta Cornelio
- Abstract
Loading... -
+
MS 12.05 - Sustainable Care System in South America
12:00 - 12:15 | Presenter: Eduardo Richardet
- Abstract
No abstract available for this presentation
-
+
MS 12.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 13 - How to Deal with CNS Metastases
- 11:00 - 12:30
- 10/17/2017
- Location: Room 502
- Type: Mini Symposium
- Track: Advanced NSCLC
- Moderators:Martin Schuler, Nir Peled
-
+
MS 13.01 - Strategic Approach to CNS Metastasis
11:00 - 11:15 | Presenter: Maurice Pérol
- Abstract
Loading... -
+
MS 13.02 - SBRT vs. WBRT
11:15 - 11:30 | Presenter: Paul Van Houtte | Author(s): D. Devriendt
- Abstract
Loading... -
+
MS 13.03 - Target Therapy for ALK/ROS1 + NSCLC with CNS Metastasis
11:30 - 11:45 | Presenter: Alice Shaw
- Abstract
No abstract available for this presentation
-
+
MS 13.04 - The Role of Chemotherapy in the Management of CNS Metastasis
11:45 - 12:00 | Presenter: Chong-Kin Liam
- Abstract
Loading... -
+
MS 13.05 - Targeted Therapy for EGFR Positive Mutant NSCLC with CNS Metastasis
12:00 - 12:15 | Presenter: Myung-Ju Ahn
- Abstract
Loading... -
+
MS 13.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 14 - QOL Evaluation in Practice from the Viewpoint of Physicians and Nurses
- 11:00 - 12:30
- 10/17/2017
- Location: Room 315
- Type: Mini Symposium
- Track: Nursing/Palliative Care/Ethics
- Moderators:Qing Zhou, Beth Eaby-Sandy
-
+
MS 14.01 - Elements to Reach the Treatment Goal of Palliation
11:00 - 11:15 | Presenter: Christian Klaus Manegold
- Abstract
Loading... -
+
MS 14.02 - Dimensions of Quality of Life in Lung Cancer
11:15 - 11:30 | Presenter: Marianne Davies
- Abstract
Loading... -
+
MS 14.03 - Estimating Prognosis - How Accurate Can We Be?
11:30 - 11:45 | Presenter: Kunihiko Kobayashi
- Abstract
Loading... -
+
MS 14.04 - Whole Person Care
11:45 - 12:00 | Presenter: Caitlin Broderick
- Abstract
No abstract available for this presentation
-
+
MS 14.05 - Quality of Life in Women with Lung Cancer and Effect of Inner Strength in Mood and QOL
12:00 - 12:15 | Presenter: Eunjung Ryu
- Abstract
Loading... -
+
MS 14.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
OA 08 - Neuroendocrine Carcinoma: Translational
- 11:00 - 12:30
- 10/17/2017
- Location: Room 311 + 312
- Type: Oral
- Track: SCLC/Neuroendocrine Tumors
- Moderators:David S Ettinger, S. Zöchbauer-Müller
-
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
OA 08.03 - Effect of TOP2A and ERCC1 Genes Polymorphism on the Efficacy and Toxicity of Cisplatin and Etoposide Therapy in SCLC Patients
11:20 - 11:30 | Presenter: Marcin Nico? | Author(s): P. Krawczyk, A. Rolska-Kopińska, A. Grenda, A. Bożyk, M. Szczyrek, J. Milanowski
- Abstract
Loading... -
+
OA 08.04 - Discussant - OA 08.01, OA 08.02, OA 08.03
11:30 - 11:45 | Presenter: Ikuo Sekine
- Abstract
No abstract available for this presentation
-
+
OA 08.05 - Major Drivers of Chemotherapy and Radiation Utilization for Limited-Stage Small Cell Lung Cancer in the United States
11:45 - 11:55 | Presenter: Stephen G Chun | Author(s): T.A. Pezzi, A.S.R. Mohammed, D.L. Schwartz, J.W. Welsh, Ritsuko Komaki, S.M. Hahn, C.D. Fuller
- Abstract
Loading... -
+
OA 08.06 - Exploratory Analysis for Predictors of Benefit of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study
11:55 - 12:05 | Presenter: Taofeek K Owonikoko | Author(s): S. Dahlberg, John Poirier, G.L. Sica, Charles M Rudin, Suresh S Ramalingam
- Abstract
Loading... -
+
OA 08.07 - Pazopanib Maintenance for Extensive Disease Small Cell Lung Cancer: a Randomized, Placebo-Controlled Phase II study (KCSG-LU12-07)
12:05 - 12:15 | Presenter: Jong-Mu Sun | Author(s): K.H. Lee, B. Kim, H. Kim, Y.J. Min, S.Y. Yi, H.J. Yun, S. Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
OA 08.08 - Discussant - OA 08.05, OA 08.06, OA 08.07
12:15 - 12:30 | Presenter: Karen L Reckamp
- Abstract
No abstract available for this presentation
-
+
OA 09 - EGFR TKI Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Thanyanan Reungwetwattana, Lecia V Sequist
-
+
OA 09.01 - Characterizing the Genomic Landscape of EGFR C797S in Lung Cancer Using ctDNA Next-Generation Sequencing
11:00 - 11:10 | Presenter: Zofia Piotrowska | Author(s): R.J. Nagy, S. Fairclough, R.B. Lanman, N. Marcoux, Scott N. Gettinger, Taofeek K Owonikoko, Suresh S Ramalingam, Lecia V Sequist
- Abstract
Loading... -
+
OA 09.02 - Osimertinib Resistance Mediated by Loss of EGFR T790M Is Associated with Early Resistance and Competing Resistance Mechanisms
11:10 - 11:20 | Presenter: Geoffrey R. Oxnard | Author(s): Y. Hu, K.F. Mileham, P. Tracy, N. Feeney, L.M. Sholl, C.P. Paweletz, K.S. Thress, Pasi A Jänne
- Abstract
Loading... -
+
OA 09.03 - TATTON Ph Ib Expansion Cohort: Osimertinib plus Savolitinib for Pts with EGFR-Mutant MET-Amplified NSCLC after Progression on Prior EGFR-TKI
11:20 - 11:30 | Presenter: Myung-Ju Ahn | Author(s): Ji-Youn Han, Lecia V Sequist, Byoung Chul Cho, J.S. Lee, Sang-We Kim, W. Su, C. Tsai, James Chih-Hsin Yang, Helena Yu, L. Horn, K. Lee, V. Haddad, M.M. Frigault, G. Ahmed, L. Yang, D. Ghiorghiu, Geoffrey R. Oxnard
- Abstract
Loading... -
+
OA 09.04 - Discussant - OA 09.01, OA 09.02, OA 09.03
11:30 - 11:45 | Presenter: Hatim Husain
- Abstract
No abstract available for this presentation
-
+
OA 09.05 - Identification of Novel Potentially Targetable Genomic Alterations in Paired Tumors with Acquired EGFR TKI Resistance by NGS
11:45 - 11:55 | Presenter: Jacqulyne Ponville Robichaux | Author(s): Y.Y. Elamin, Jianjun Zhang, A. Futreal, E. Roarty, W. Rinsurongkawong, J. Lewis, H.T. Tran, Stephen Swisher, John V Heymach
- Abstract
Loading... -
+
OA 09.06 - A Phase Ib Trial of Savolitinib plus Gefitinib for Chinese Patients with EGFR-Mutant MET-Amplified Advanced NSCLC
11:55 - 12:05 | Presenter: Jin -Ji Yang | Author(s): Jian Fang, Y. Shu, J. Chang, G. Chen, J. He, W. Li, X. Liu, N. Yang, Caicun Zhou, J. Huang, L. Yang, A.A. Handzel, M.M. Frigault, G. Ahmed, C. Egile, S. Morgan, Yi-Long Wu
- Abstract
Loading... -
+
OA 09.07 - Clonality of c-MET Copy Number Gain as a Determinant of Primary TKI Resistance in EGFR-Mutant NSCLC
12:05 - 12:15 | Presenter: Gillianne Lai | Author(s): R. Nahar, T. Lim, X. Kwang, P.J.R. Liew, J. Lim, Z.W. Aung, A. Takano, Wan-Teck Lim, D.P. Lau, Wan Ling Tan, M. Ang, C.K. Toh, B.S. Tan, A. Devanand, C.W. Too, A. Gogna, B.H. Ong, Tina Koh, R. Kanesvaran, Q.S. Ng, A. Jain, J. Yuan, T.K. Lim, A.S. Lim, A. Hillmer, W. Zhai, G. Iyer, E.H. Tan, W. Tam, Daniel SW Tan
- Abstract
Loading... -
+
OA 09.08 - Discussant - OA 09.05, OA 09.06, OA 09.07
12:15 - 12:30 | Presenter: Howard L West
- Abstract
No abstract available for this presentation
-
+
PC 02 - Is Radiotherapy Necessary for Extensive SCLC? (Thoracic Radiation/PCI)
- 11:00 - 12:30
- 10/17/2017
- Location: F203 + F204 (Annex Hall)
- Type: Pros & Cons
- Track: SCLC/Neuroendocrine Tumors
- Moderators:J.B. Sørensen, Young-Taek Oh
-
+
PC 02.01 - Thoracic Radiation - YES
11:00 - 11:20 | Presenter: Ritsuko Komaki
- Abstract
Loading... -
+
PC 02.02 - Thoracic Radiation - NO
11:20 - 11:40 | Presenter: Sue S Yom
- Abstract
No abstract available for this presentation
-
+
PC 02.03 - PCI---YES
11:40 - 12:00 | Presenter: Andrea Bezjak
- Abstract
Loading... -
+
PC 02.04 - PCI---NO
12:00 - 12:20 | Presenter: Takashi Seto
- Abstract
Loading... -
+
PC 02.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation